{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:30:20Z","timestamp":1774949420165,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Public Health"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.puhe.2020.06.024","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T23:27:28Z","timestamp":1595978848000},"page":"341-347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["The burden and epidemiology of hepatitis B and hepatitis D in Georgia: findings from the national seroprevalence survey"],"prefix":"10.1016","volume":"185","author":[{"given":"A.","family":"Kasradze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5772-7046","authenticated-orcid":false,"given":"S.","family":"Shadaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kuchuloria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gamkrelidze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Nasrullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Gvinjilia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8390-3325","authenticated-orcid":false,"given":"D.","family":"Baliashvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Chitadze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kodani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tejada-Strop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Drobeniuc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Hagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Imnadze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Averhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.puhe.2020.06.024_bib1","series-title":"Global hepatitis report","year":"2017"},{"key":"10.1016\/j.puhe.2020.06.024_bib2","unstructured":"World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2019 Global summary. Available at: https:\/\/www.who.int\/immunization\/monitoring_surveillance\/data\/gs_gloprofile.pdf?ua=1. (Accessed 10 March 2020)."},{"issue":"2","key":"10.1016\/j.puhe.2020.06.024_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S2468-1253(18)30270-X","article-title":"Accelerating the elimination of viral hepatitis: a lancet gastroenterology & hepatology commission","volume":"4","author":"Cooke","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"41","key":"10.1016\/j.puhe.2020.06.024_bib4","first-page":"1132","article-title":"National progress toward hepatitis C elimination\u2014Georgia 2015\u20132016","volume":"65","author":"Gvinjilia","year":"2016","journal-title":"MMWR"},{"issue":"28","key":"10.1016\/j.puhe.2020.06.024_bib5","first-page":"753","article-title":"Launch of a nationwide hepatitis C elimination program\u2014Georgia, April 2015","volume":"64","author":"Mitruka","year":"2015","journal-title":"MMWR"},{"issue":"29","key":"10.1016\/j.puhe.2020.06.024_bib6","first-page":"773","article-title":"The role of screening and treatment in national progress toward hepatitis C elimination \u2014 Georgia, 2015\u20132016","volume":"66","author":"Nasrullah","year":"2017","journal-title":"MMWR"},{"key":"10.1016\/j.puhe.2020.06.024_bib7","series-title":"World bank country and lending groups","year":"2018"},{"key":"10.1016\/j.puhe.2020.06.024_bib8","series-title":"Main Results. General Information","author":"General Population Census","year":"2014"},{"issue":"S3","key":"10.1016\/j.puhe.2020.06.024_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-019-6784-3","article-title":"Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination","volume":"19","author":"Hagan","year":"2019","journal-title":"BMC Publ Health"},{"key":"10.1016\/j.puhe.2020.06.024_bib10","unstructured":"World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2019 Global summary. Country data: Georgia Available at: http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/countries?countrycriteria%5Bcountry%5D%5B%5D=GEO. (Accessed 10 March 2020)."},{"key":"10.1016\/j.puhe.2020.06.024_bib11","unstructured":"Anti-HBc Ab, EIA IVD, Dia.Pro. Diagnostic Bioprobes Srl., Italy. Dia.Pro. Diagnostic Bioprobes Srl., Italy. https:\/\/www.diapro.it\/index.php\/products\/elisa\/hepatitis\/hepatitis-b\/hbc-ab-detail. (Accessed 13 May 2019)."},{"key":"10.1016\/j.puhe.2020.06.024_bib12","unstructured":"HBsAg EIA IVD, Dia.Pro. Diagnostic Bioprobes Srl., Italy. https:\/\/www.diapro.it\/index.php\/products\/elisa\/hepatitis\/hepatitis-b\/hbs-ag-detail. (Accessed 13 May 2019)."},{"key":"10.1016\/j.puhe.2020.06.024_bib13","unstructured":"HBs Ag Conf, Dia.Pro. Diagnostic Bioprobes Srl., Italy. https:\/\/www.diapro.it\/index.php\/products\/elisa\/hepatitis\/hepatitis-b\/hbs-ag-conf-detail. (Accessed 20 September 2019)."},{"key":"10.1016\/j.puhe.2020.06.024_bib14","unstructured":"VITROS immunodiagnostic products, anti-HBc reagent pack and calibrator, United States. javascript:f_openPopup('aHBc_GEM1211_US_EN_I_13_1.pdf', 'http:\/\/techdocs.orthoclinicaldiagnostics.com','\/IFU\/ContentPages\/displayDoc.aspx'). (Accessed 4 December 2019)."},{"key":"10.1016\/j.puhe.2020.06.024_bib15","unstructured":"VITROS Immunodiagnostic Products, HBsAg Reagent Pack and Calibrator, United States. javascript:f_openPopup('HBsAg_GEM1201_US_EN_I_13_1.pdf', 'http:\/\/techdocs.orthoclinicaldiagnostics.com','\/IFU\/ContentPages\/displayDoc.aspx'). (Accessed 4 December 2019)."},{"issue":"2","key":"10.1016\/j.puhe.2020.06.024_bib16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jviromet.2013.07.033","article-title":"One-step real-time PCR assay for detection and quantitation of hepatitis D virus RNA","volume":"193","author":"Kodani","year":"2013","journal-title":"J\u00a0Virol Methods"},{"issue":"8","key":"10.1016\/j.puhe.2020.06.024_bib17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/occmed\/kqs121","article-title":"Occupational exposure to body fluids among health care workers in Georgia","volume":"62","author":"Butsashvili","year":"2012","journal-title":"Occup Med (Oxford, England)"},{"issue":"10003","key":"10.1016\/j.puhe.2020.06.024_bib18","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.puhe.2020.06.024_bib19","doi-asserted-by":"crossref","first-page":"a021576","DOI":"10.1101\/cshperspect.a021576","article-title":"Hepatitis D virus: introduction and epidemiology","volume":"5","author":"Rizzetto","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.puhe.2020.06.024_bib20","first-page":"3","article-title":"A\u00a0review on hepatitis D: from virology to new therapies","volume":"17","author":"Mentha","year":"2019","journal-title":"J\u00a0Adv Res"},{"key":"10.1016\/j.puhe.2020.06.024_bib21","doi-asserted-by":"crossref","first-page":"S212","DOI":"10.1016\/S0168-8278(03)00331-3","article-title":"Delta hepatitis: an update","volume":"39","author":"Farzi","year":"2003","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.puhe.2020.06.024_bib22","first-page":"30","article-title":"Prevalence of viral hepatitis among residents of South Kazakhstan region","volume":"171","author":"Nersesov","year":"2016","journal-title":"Gepatologia"},{"key":"10.1016\/j.puhe.2020.06.024_bib23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1017\/S0950268899003003","article-title":"Prevalence of hepatitis B, D and C virus infections among children and pregnant women in Moldova: additional evidence supporting the need for routine hepatitis B vaccination of infants","volume":"123","author":"Drobeniuc","year":"1999","journal-title":"Epidemiol Infect"},{"issue":"6","key":"10.1016\/j.puhe.2020.06.024_bib24","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/hep.28957","article-title":"A\u00a0novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus\u2013infected Mongolians","volume":"66","author":"Chen","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.puhe.2020.06.024_bib25","series-title":"Presented at the 6th national hepatitis C elimination workshop, Tbilisi, Georgia, March 7","article-title":"Vaccination against hepatitis B in Georgia","author":"Jabidze","year":"2019"},{"key":"10.1016\/j.puhe.2020.06.024_bib26","series-title":"Hepatitis B catch-up vaccination program in Georgia","year":"2012"},{"key":"10.1016\/j.puhe.2020.06.024_bib27","unstructured":"World Health Organization Regional Office for Europe. Action plan for the health sector response to viral hepatitis in the WHO European Region. Available at: http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0008\/357236\/Hepatitis-9789289052870-eng.pdf?ua=1. (Accessed 10 March 2020)."},{"key":"10.1016\/j.puhe.2020.06.024_bib28","unstructured":"Legislative herald of Georgia. Available at: https:\/\/matsne.gov.ge\/ka\/document\/view\/4454340?publication=0. (Accessed 29 May 2019)."},{"issue":"2","key":"10.1016\/j.puhe.2020.06.024_bib29","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/hep.26400","article-title":"Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients","volume":"58","author":"Tyson","year":"2013","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.puhe.2020.06.024_bib30","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1440-1746.2008.05384.x","article-title":"Hepatitis B virus\/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment","volume":"23","author":"Chu","year":"2008","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"28","key":"10.1016\/j.puhe.2020.06.024_bib31","doi-asserted-by":"crossref","first-page":"773","DOI":"10.15585\/mmwr.mm6728a2","article-title":"Access to treatment for hepatitis B virus infection - worldwide, 2016","volume":"67","author":"Hutin","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350620302626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350620302626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:35:57Z","timestamp":1758501357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033350620302626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":31,"alternative-id":["S0033350620302626"],"URL":"https:\/\/doi.org\/10.1016\/j.puhe.2020.06.024","relation":{},"ISSN":["0033-3506"],"issn-type":[{"value":"0033-3506","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The burden and epidemiology of hepatitis B and hepatitis D in Georgia: findings from the national seroprevalence survey","name":"articletitle","label":"Article Title"},{"value":"Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.puhe.2020.06.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}